Description:
Naringin inhibits hepatic P-glycoprotein (P-gp) and some drug-metabolizing cytochrome P450 enzymes, including CYP3A4 and CYP1A2, which may result in drug-drug interactions. Naringin can be used as an edible additive, mainly for gum, refreshing drinks, etc.
- Molecular Weight:580.53
- Boiling Point:928.1±65.0 °C at 760 mmHg
- Melting Point:166°C
- Purity:>98%
Molecular Formula:
C27H32O14
Canonical SMILES:
CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC=C(C=C5)O)O)CO)O)O)O)O)O
InChI:
InChI=1S/C27H32O14/c1-10-20(32)22(34)24(36)26(37-10)41-25-23(35)21(33)18(9-28)40-27(25)38-13-6-14(30)19-15(31)8-16(39-17(19)7-13)11-2-4-12(29)5-3-11/h2-7,10,16,18,20-30,32-36H,8-9H2,1H3/t10-,16-,18+,20-,21+,22+,23-,24+,25+,26-,27+/m0/s1
InChIKey:
DFPMSGMNTNDNHN-ZPHOTFPESA-N
Appearance:
Powder
Application:
antioxidant, anticancer, anti-atherogenic
Storage: 0-6°C
Synonyms:
Aurantiin; AI3-19008; AI319008; AI3 19008; Naringin; Naringoside Weitere Informationen finden Sie
hier